2017-10-10 22:47:52 UTC

Apply Biomarkers to Better Target Therapies to IBD Patients

Oct. 12, 2017

Dr. Lee A. Denson will present his findings on biomarkers in Las Vegas at the Crohn’s & Colitis Congress.

Science and treatment advances are moving fast in inflammatory bowel diseases (IBD), and it is imperative to stay up-to-date and apply the latest research and clinical algorithms to improve care for patients. Hear from foremost IBD researchers and practitioners at the Crohn’s & Colitis Congress™ on Jan. 18-20, 2018 in Las Vegas, as you learn alongside multi-disciplinary IBD professionals to form an all-inclusive care perspective.

In Dr. Lee A. Denson’s presentation Biomarkers for Precision Medicine, you’ll learn how to apply current and upcoming biomarkers in clinical practice to better target therapies to individual patients. Recent studies have validated biomarkers that can be used now to improve patient outcomes and guide therapeutic choices.

The Crohn’s & Colitis Congress is a partnership of the Crohn’s & Colitis Foundation and AGA. Learn more, submit an abstract and register today at www.crohnscolitiscongress.org.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.